CJC-1295 (No DAC; Modified GRF 1–29) + Ipamorelin is a research peptide blend combining a GHRH analogue and a selective ghrelin receptor agonist. Experimental literature evaluates its coordinated effects on growth hormone axis signaling pathways. Laboratory models investigate receptor-level interactions and endocrine feedback mechanisms under controlled conditions without implying human outcomes.
Products will arrive in a lyophilized (powder) form to maximize stability and shelf life.
$79